HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher R Williams Selected Research

Christopher R Williams Research Topics

Disease

26Prostatic Neoplasms (Prostate Cancer)
01/2019 - 02/2002
9Neoplasms (Cancer)
01/2017 - 02/2002
2Urinary Tract Infections (Urinary Tract Infection)
12/2018 - 01/2016
2Urinary Incontinence
01/2016 - 09/2012
2Prostatic Intraepithelial Neoplasia
10/2015 - 01/2012
2Carcinogenesis
01/2012 - 01/2012
2Renal Cell Carcinoma (Grawitz Tumor)
01/2011 - 05/2005
1Sepsis (Septicemia)
12/2018
1Abdominal Obesity
11/2017
1Body Weight (Weight, Body)
11/2017
1Obesity
11/2017
1Aortic Aneurysm (Aneurysm, Aortic)
10/2017
1Hemorrhage
10/2016
1Chronic Obstructive Pulmonary Disease (COPD)
01/2016
1Urachal cancer
01/2015
1Urachal adenocarcinoma
01/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2014
1Pain (Aches)
04/2013
1Hip Fractures (Intertrochanteric Fractures)
04/2013
1Urethral Stricture
04/2013
1Tibial Fractures (Fracture, Tibial)
01/2013
1Urge Urinary Incontinence (Urge Incontinence)
09/2012
1Erectile Dysfunction
09/2012
1Thrombocytopenia (Thrombopenia)
11/2010
1Inflammation (Inflammations)
10/2007
1Necrosis
10/2007
1Kidney Neoplasms (Kidney Cancer)
12/2005
1Renal Insufficiency (Renal Failure)
05/2005
1Glioblastoma (Glioblastoma Multiforme)
02/2002
1Glioma (Gliomas)
02/2002

Drug/Important Bio-Agent (IBA)

3Testosterone (Sustanon)FDA Link
01/2019 - 03/2012
3Catechin (Z 7300)IBA
11/2017 - 10/2015
3TeaIBA
11/2017 - 10/2015
3Biomarkers (Surrogate Marker)IBA
11/2017 - 01/2012
3Protons (Proton)IBA
01/2016 - 03/2012
3CobaltIBA
03/2014 - 01/2012
3AndrogensIBA
03/2014 - 01/2012
2polyphenon EIBA
10/2015 - 01/2012
2Docetaxel (Taxotere)FDA Link
03/2014 - 01/2012
2Dendrimers (Dendrons)IBA
11/2008 - 01/2008
1Indicators and Reagents (Reagents)IBA
11/2017
1Caffeine (No Doz)FDA LinkGeneric
11/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2016
1Lapatinib (GW572016)FDA Link
04/2014
1OSI 027IBA
04/2014
1PP242IBA
04/2014
1Mechanistic Target of Rapamycin Complex 1IBA
04/2014
1Mechanistic Target of Rapamycin Complex 2IBA
04/2014
1ErbB Receptors (EGF Receptor)IBA
04/2014
1Analgesics (Analgesic Drugs)IBA
04/2013
1Hormones (Hormone)IBA
09/2012
1Glutamine (L-Glutamine)FDA Link
01/2012
1IsoflavonesIBA
01/2012
1Androgen Receptors (Androgen Receptor)IBA
01/2012
1Proto-Oncogene Proteins c-etsIBA
11/2010
1ChemokinesIBA
04/2010
1Biological ProductsIBA
04/2010
1Poly(amidoamine)IBA
11/2008
1Contrast MediaIBA
01/2008
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
10/2007
1Proteins (Proteins, Gene)FDA Link
10/2007
1Heat-Shock Proteins (Heat-Shock Protein)IBA
10/2007
1tanespimycin (17AAG)IBA
10/2007
1Cytosine DeaminaseIBA
02/2002
1AntimetabolitesIBA
02/2002
1Fluorouracil (Carac)FDA LinkGeneric
02/2002
1Antineoplastic Agents (Antineoplastics)IBA
02/2002

Therapy/Procedure

14Proton Therapy
01/2019 - 01/2012
8Radiotherapy
01/2019 - 12/2005
7Therapeutics
01/2016 - 12/2005
3Transurethral Resection of Prostate (TURP)
01/2016 - 04/2013
3Aftercare (After-Treatment)
04/2014 - 03/2012
3Chemoprevention
03/2012 - 01/2012
2Nephrectomy
01/2011 - 05/2005
1Perioperative Period
10/2017
1Cryosurgery
05/2016
1Salvage Therapy
05/2016
1Lymph Node Excision (Lymph Node Dissection)
01/2015
1Cystectomy
01/2015
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2014
1Transplantation
01/2013
1Injections
10/2007
1Neoadjuvant Therapy
12/2005
1Drug Therapy (Chemotherapy)
02/2002